Profound

TORONTO, June 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the…

TORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- Profound Medical…

TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical…

TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical…

<!-- Name:DistributionId Value:8749242 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the…